Group 1 - The core viewpoint of the news is that Weigao Blood Purification has shown positive financial performance with a slight increase in stock price and notable trading activity on January 21, 2025 [1] - On January 21, 2025, Weigao Blood Purification's stock price increased by 1.24%, with a trading volume of 107 million yuan, and a net financing purchase of 1.71 million yuan [1] - As of January 21, 2025, the total balance of margin trading for Weigao Blood Purification is 133 million yuan, which accounts for 8.08% of its market capitalization [1] Group 2 - As of September 30, 2025, the number of shareholders for Weigao Blood Purification is 24,800, a decrease of 20.95% from the previous period, while the average circulating shares per person increased by 26.51% to 1,535 shares [2] - For the period from January to September 2025, Weigao Blood Purification achieved an operating income of 2.736 billion yuan, representing a year-on-year growth of 3.45%, and a net profit attributable to shareholders of 341 million yuan, with a year-on-year increase of 7.92% [2] - Since its A-share listing, Weigao Blood Purification has distributed a total of 65.8213 million yuan in dividends [3]
威高血净1月21日获融资买入1250.50万元，融资余额1.33亿元